Intrauterine Ureaplasma is associated with small airway obstruction in extremely preterm infants

Pediatr Pulmonol. 2022 Nov;57(11):2763-2773. doi: 10.1002/ppul.26098. Epub 2022 Aug 17.

Abstract

Background: The long-term follow-up of lung function (LF) in extremely preterm (EP) infants with bronchopulmonary dysplasia (BPD) has shown a worldwide increase in small airway obstructions (SAO).

Objectives: We investigated the relationships between intrauterine Ureplasma infection in EP infants and bubbly/cystic lung, BPD, and SAO at school age.

Methods: Placental pathology, placental Ureaplasma DNA (pU-DNA), and cord blood immunoglobulin M (IgM) (C-IgM) were investigated in 360 EP infants born from 1981 to 2004. Maternal amniotic inflammatory response (M-AIR) scores and hemosiderin deposition (HD) were estimated in the chorioamnion. The study subjects were divided into groups based on their M-AIR scores. Their LF at school age was compared with those of 33 healthy siblings.

Findings: pU-DNA and C-IgM were significantly related to SAO at school age (p < 0.012). M-AIR score 3 and pU-DNA >1000 units had an odds ratio (OR) of 35 (95% confidence interval: 10-172) and 18 (5.6-67) for bubbly/cystic lung, and 11 (3.1 - 43) and 31 (4.5-349) for severe BPD, and 5.3 (2.1-11) and 12 (2.4-74) for SAO, respectively. The ORs of surfactant treatment, BPD grade III, O2 at 40 weeks, HD, and C-IgM >30 mg/dl for SAO were 0.21 (0.075-0.58), 5.3 (2.1-15), 2.5 (1.4-4.6), 3.6 (1.5-9.1) and 2.5 (1.0-5.2). 84% (90/107) SAO infants showed no or mild BPD in infancy, and 61% of infants had no severe CAM.

Conclusion: Our long-term cohort study of LF in EP infants revealed that intrauterine Ureaplasma was associated with bubbly/cystic lung, severe BPD, and SAO at school age.

Keywords: Ureaplasma; bronchopulmonary dysplasia; bubbly/cystic lung; extremely preterm infant; small airway obstruction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Airway Obstruction*
  • Bronchopulmonary Dysplasia* / complications
  • Cohort Studies
  • Female
  • Gestational Age
  • Hemosiderin
  • Humans
  • Immunoglobulin M
  • Infant
  • Infant, Extremely Premature
  • Infant, Newborn
  • Placenta
  • Pregnancy
  • Surface-Active Agents
  • Ureaplasma

Substances

  • Immunoglobulin M
  • Surface-Active Agents
  • Hemosiderin